Publications by authors named "Minke Smits"

Claim this Profile
S
Substitution of ifosfamide for cyclophosphamide in the TI-CE regimen: pharmacology and dose justification in a patient with refractory metastatic germ-cell tumor post-nephrectomy-A case report.
Lotte M G Hulskotte, Loek A W de Jong, Alwin D R Huitema, Joost Sijm, Ingrid Desar, Minke Smits

Cancer Chemother Pharmacol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular reflex testing in patients with early metastatic castration-resistant prostate cancer within the PROMPT-study.
Iris S H Kloots, Peter H J Slootbeek, Sofie H Tolmeijer, Sandra van Wilpe, Minke Smits

Br J Cancer· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cemiplimab in Locally Advanced or Metastatic Secondary Angiosarcomas (CEMangio): A Phase II Clinical Trial and Biomarker Analyses.
Stefan G van Ravensteijn, Jacco J de Haan, Hans Gelderblom, Maikel J L Nederkoorn, Melissa H S Hillebrandt-Roeffen, Minke Smits

Clin Cancer Res· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detection and localization of early- and late-stage cancers using platelet RNA.
Sjors G J G In 't Veld, Mohammad Arkani, Edward Post, Mafalda Antunes-Ferreira, Silvia D'Ambrosi, A Josien Smits, Minke Smits

Cancer Cell· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reovirus mutant jin-3 exhibits lytic and immune-stimulatory effects in preclinical human prostate cancer models.
Arjanneke F van de Merbel, Geertje van der Horst, Maaike H van der Mark, Selas T F Bots, Diana J M van den Wollenberg, Minke Smits

Cancer Gene Ther· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of molecular tumour board discussion on targeted therapy allocation in advanced prostate cancer.
Peter H J Slootbeek, Iris S H Kloots, Minke Smits, Inge M van Oort, Winald R Gerritsen

Br J Cancer· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Impact of molecular tumour board discussion on targeted therapy allocation in advanced prostate cancer.
Peter H J Slootbeek, Iris S H Kloots, Minke Smits, Inge M van Oort, Winald R Gerritsen

Br J Cancer· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prior PSMA PET-CT Imaging and Hounsfield Unit Impact on Tumor Yield and Success of Molecular Analyses from Bone Biopsies in Metastatic Prostate Cancer.
Minke Smits, Kamer Ekici, Samhita Pamidimarri Naga, Inge M van Oort, Michiel J P Sedelaar

Cancers (Basel)· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Ga-PSMA-Guided Bone Biopsies for Molecular Diagnostics in Patients with Metastatic Prostate Cancer.
Anouk C de Jong, Minke Smits, Job van Riet, Jurgen J Fütterer, Tessa Brabander

J Nucl Med· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Responsiveness to Immune Checkpoint Inhibitors Is Associated With a Peripheral Blood T-Cell Signature in Metastatic Castration-Resistant Prostate Cancer.
Donjete Simnica, Minke Smits, Edith Willscher, Lorenzo F Fanchi, Iris S H Kloots

JCO Precis Oncol· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Probing single-cell metabolism reveals prognostic value of highly metabolically active circulating stromal cells in prostate cancer.
Francesca Rivello, Kinga Matuła, Aigars Piruska, Minke Smits, Niven Mehra

Sci Adv· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The genomic landscape of metastatic castration-resistant prostate cancers reveals multiple distinct genotypes with potential clinical impact.
Lisanne F van Dessel, Job van Riet, Minke Smits, Yanyun Zhu, Paul Hamberg

Nat Commun· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular biomarkers to guide precision medicine in localized prostate cancer.
Minke Smits, Niven Mehra, Michiel Sedelaar, Winald Gerritsen, Jack A Schalken

Expert Rev Mol Diagn· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis